Development and in vivo evaluation of buccal tablets prepared using danazol–sulfobutylether 7 β‐cyclodextrin (SBE 7) complexes
- 1 July 2002
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 91 (7), 1659-1668
- https://doi.org/10.1002/jps.10163
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether β-cyclodextrins (SBE) and danazol–SBE inclusion complexesInternational Journal of Pharmaceutics, 2001
- Bioavailability of danazol-hydroxypropyl-β-cylodextrin complex by different routes of administrationInternational Journal of Pharmaceutics, 1996
- Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug DeliveryJournal of Pharmaceutical Sciences, 1996
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996
- Characterization and bioavailability of danazol-hydroxypropyl β-cyclodextrin coprecipitatesInternational Journal of Pharmaceutics, 1996
- The oral cavity as a site for systemic drug deliveryAdvanced Drug Delivery Reviews, 1994
- A simple equation for the description of solute release. III. Coupling of diffusion and relaxationInternational Journal of Pharmaceutics, 1989
- γ-Cyclodextrin: Testosterone Complex Suitable for Sublingual AdministrationJournal of Pharmaceutical Sciences, 1987
- Buccal and oral bioavailability of naloxone and naltrexone in ratsInternational Journal of Pharmaceutics, 1987
- A model for steroid transport across biological membranesJournal of Pharmacy and Pharmacology, 1975